Skip to main content

Table 3 Demographic and clinical characteristics at baseline

From: The efficacy of QingfengGanke granule in treating postinfectious cough in pathogenic wind invading lungs syndrome: a multicenter, randomized, double-blind, placebo-controlled trial

Characteristics

Group A (n = 57)

Group B (n = 57)

Group C (n = 59)

P values*

Age (years)

44.37 ± 12.38

43.07 ± 12.67

44.07 ± 12.65

0.8663

Gender (female/%)

35 (61.40)

35 (61.40)

31 (52.54)

0.5336

Body weight (kg)

62.41 ± 9.91

62.45 ± 10.76

63.44 ± 10.87

0.6680

Height (cm)

164.26 ± 7.89

163.22 ± 7.99

164.47 ± 8.59

0.6097

Former smoker (n (%))

10 (17.54)

5 (8.77)

5 (8.47)

0.2255

Cough duration (days)

33.00 ± 10.32

29.96 ± 7.09

30.80 ± 8.96

0.3685

Previous diagnosis of PIC (n (%))

9 (15.79)

8 (14.04)

10 (16.95)

0.9696

VAS score

6.04 ± 1.44

5.90 ± 1.23

5.96 ± 1.33

0.8341

CSS

3.84 ± 0.80

3.79 ± 0.77

3.86 ± 0.84

0.9648

Daytime CSS

2.12 ± 0.38

2.02 ± 0.35

2.14 ± 0.43

0.2084

Nighttime CSS

1.72 ± 0.65

1.77 ± 0.68

1.73 ± 0.69

0.7752

CQLQ score

64.51 ± 9.58

64.95 ± 7.31

64.78 ± 6.46

0.9068

TCM syndrome score

12.02 ± 2.60

11.46 ± 1.97

11.97 ± 2.17

0.1492

  1. Values are reported as mean ± SD or as frequency (%).
  2. CQLQ cough-specific quality of life questionnaire, CSS cough symptom score, PIC postinfectious cough, TCM traditional Chinese medicine, VAS visual analogue scale.
  3. * P values obtained via variance analysis for continuous variables, or Chi square tests for categorical variables.